Kidney transplantation offers best hope to women with end stage renal disease and want to be pregnant. It is recommended that women in childbearing age should recieve before and after kidney transplantation contraception counseling, and counseling about teratogenic immunosuppressive drugs which must be replaced with immunosuppresivess which are consideres safe during pregnancy. Pregnancy should be avoided in the first year after transplantation, to reduce the risk of maternal and fetal complications. Immunosuppressive drugs, such as calcineurin inhibitors (cyclosporine, tacrolimus), azathioprine and low dose prednisone are considered safe during pregnancy. Mycophenolate mofetil and sirolimus should be stopped 6 weeks before conception. The factors associated with poor pregnancy outcomes include hypertension, serum creatinine >1,4 mg/dL and proteinuria. Maternal complications that occur more commonly than the general population include hypertension, pree-eclampsia and infections. Fetal complications that occur more commonly than the general population include intrauterine growth retardation, low birth weight, premature birth. In the current guidelines vaginal delivery is recommended for most transplant recipient, cesarean section should be done for obstetric indications. Pregnant women should be followed up by a transplant nephrologist, obstetrician and neonatologist, because these pregnancies are high risk. Breast-feeding is not contraindicated if they are the same as they been during pregnancy. Pregnancy without risk factors not increased the risk of transplant rejection.